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The  existence,  in  several  species,  of  two  major  types  of  homocytotropic 
antibodies has been recognized and reviewed previously (1). In the preceding 
paper (2)  conditions were described for studying in vitro the antigen-induced 
release  of  histamine  in  the  rat  IgE  and  IgGa antibody-mediated  systems. 
The present paper further characterizes the properties of the IgGa antibody- 
mediated reaction and presents evidence that homologous IgGa and IgE anti- 
bodies utilize the same cellular receptors in the pathway leading to the release 
of histamine. 
Materials  and Methods 
The media, antigen, and antibody preparations used in this study were the same as those 
previously described (2). Except where specifically indicated, the conditions of the experi- 
ments were those found to yield optimum results in the previous study  (2). 
RESULTS 
Characteristics of the IgGa Antibody-Mediated  System 
Evidence for the  Transient Interaction  of IgGa Antibody and  Target Cell.- 
It has been previously shown that mouse IgG1 antibodies prepare mixed mouse 
peritoneal cells for antigen-induced release of histamine in vitro (3). The inter- 
action of mouse IgGl antibodies and peritoneal cells is transient and does not 
persist  after washing  of  the  cells.  The  characteristics  of  the  rat  IgGa anti- 
body-target cell interaction were explored in the following experiments. 
* This work was aided by grants AI-07722, AI-10129, AM-3564, and AM-5067 from the 
National Institutes of Health, grant T451A from the American Cancer Society, Inc., and 
grant from the John A. Hartford Foundation, Inc. 
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Rat peritoneal cell suspensions were exposed to an IgGa anti-dinitrophenyl 
(DNP) 1 antibody fraction for  1 hr  at 30°C,  followed by the addition of dini- 
trophenyl-bovine serum albumin (DNP-BSA)  antigen; a  net histamine release 
of 9%  was  achieved.  In  contrast,  there was  no  specific release  of  histamine 
after the addition of  antigen  to  cells which  had  been  washed  once  after  ex- 
posure to the IgGa antibody fraction (Table I). In another experiment, peri-- 
toneal  cells were  incubated  in  medium  I  for  1  hr  at  30°C,  followed by  the 
simultaneous addition of IgGa antibody fraction and antigen; a  net histamine 
TABLE I 
Effect of Preincubation of Peritoneal Cells with IgGa Antibody or of Washing of the Cells before 
Challenge with Antigen 
Prechallenge treatment  Additions made at time of challenge  Net histamine  release 
(%) 
A. Antibody*  Antigen  9 
Antibody, wash  Antigen  0 
B.  Antibody:~  Antigen  16 
None  Antigen and antibody  13 
* Eight tubes, each containing 2.5 )<  106 mixed peritoneal cells suspended  in medium I 
(but without added Ca  ++, A1  ++, or heparin)  were incubated for 1 hr at 30°C. IgGa antibody 
fraction was added at a dilution of 1:10 as indicated; antigen challenge was initiated by the 
addition of 0, 100, 500, i000, 2000, and 5090 ng/ml DNP-BSA to duplicate tubes with mix- 
ing. The final volume in each tube was 80/zl and the cell buttons contained a total of 2600 
ng histamine.  Antigen challenge was continued for 15 min at 30°C. Maximum net release 
was obtained at 1000 ng/ml DNP-BSA; spontaneous  release of histamine was 1.2%. 
:~ Conditions as above, except that antibody fraction was used at a dilution of 1:25  and 
antigen at 0, 500, 1000, 2000, and 4000 ng DNP-BSA/ml. Cells in each tube contained 1280 
ng histamine; spontaneous  release was 2.5%. 
release of 13 % was achieved. Addition of antigen to cells treated with the IgGa 
antibody fraction for  i  hr  yielded a  net histamine release of  16%  in  this  ex- 
periment  (Table  I).  The  findings  in  this  series  of  experiments  suggest  that 
the IgGa antibody-mediated reaction does not require a  latent period for pre- 
paring target cells for antigen-induced release of histamine and that this anti- 
body is not firmly bound to the target cell. 
Effects of Normal Rat Serum.--Since IgGa antibodies can activate the com- 
plement system in the presence of antigen (4), it was of interest to determine 
whether  normal  rat serum  would potentiate  the IgGa antibody-mediated re- 
lease  of  histamine.  Fig.  1  shows  the  results  obtained  by  adding  normal  rat 
1 Abbreviations used in this paper: DNP, dinitrophenyl; DNP-BSA, dinitrophenyl-bovine 
serum albumin; SRS-A, slow reacting substance  of anaphylaxis. 774  INTERACTION  OF  IGGA AND  IGE  AT  THE  TARGET  CELL 
serum (CHs0  [5]  =  120 units/ml)  or complement-depleted rat serum (CHs0  = 
5.6  units/ml)  to  the  IgGa  antibody-mediated system.  Complement-depleted 
serum was  obtained from  rats  treated 45  hr previously with 3  units  of cobra 
venom factor (6,  7). The presence of either serum in concentrations up to 1% 
potentiated the release of histamine; this effect was diminished at higher serum 
concentrations.  The  results  of  these  experiments  suggest  that  the  effect  of 
serum did not depend upon an intact complement system. 
In the range of serum  concentration from 3  to 5 %,  the effect on histamine 
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FIG. 1.  Effect of added normal rat serum  (t, --)  and serum from cobra venom factor- 
treated rats (O, .....  ) on release of histamine in vitro in the IgGa antibody-mediated system. 
Incubation medium and conditions are cited in Table I. Maximum net release was obtained 
with 500 ng of DNP-BSA/ml. 
release was variable; enhancement was observed in experiments shown in Fig. 1 
and inhibition was observed in experiments shown in Fig. 2. However, at higher 
concentrations  of serum,  inhibition  of histamine release was  consistently ob- 
served (Fig. 2). 
Effect  of  Exposure  of  Peritoneal  Cells to  an  IgGa  Antibody  Fraction  and 
Antigen  at O°C.--It has been  previously noted  in other in vitro systems that 
exposure of sensitized tissues or cells to antigen  at 0°C  does not  lead to  the 
release of histamine.  Furthermore,  rewarming of such  tissues after a  suitable 
interval also does not lead to the release of histamine, even after the introduc- 
tion of additional antigen (8, 9). Rat peritoneal cells were exposed to an IgGa 
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then  rewarmed  and  held  at  30°C  for  30  rain.  The  net  release  of  histamine 
was 32,  14,  and 4%  after preincubation for 0, 60,  and 150 rain at 0°C, respec- 
tively.  The  decrease  in  the  amount  of histamine  released  in  this  experiment 
might  have  been  due  to  the  inactivation  of  the  target  cells  by  either  cold 
incubation per se or in the presence of antigen-antibody complexes,  or due to 
the inability  of antigen-antibody complexes formed during prolonged incuba- 
tion to induce the release of histamine after the rewarming period. To evaluate 
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FIG. 2. Effect of added normal rat serum on release of histamine  in the IgGa antibody- 
mediated reaction. Reaction conditions as in paper I, Fig. 1 (2). The cells in each tube contained 
1870 ng of histamine; spontaneous release of histamine was 2.5%. Results were obtained with 
125 ng of DNP-BSA/ml. No serum  (O,  ), 3% normal  serum (O, ----), or 12.5% nor- 
mal serum (X, -----) was added to the reaction mixtures. 
the first possibilities,  peritoneal  cells were held  at 0°C for  1 hr,  washed,  and 
exposed  to  an IgGa antibody fraction  and  antigen  at  30°C;  a  net  histamine 
release  of 33 %  was  achieved.  Control  cells  challenged  without  prior  incuba- 
tion  0°C  with  the  same  antibody-antigen  mixture  showed  a  net  release  of 
histamine of 40%. In contrast, cells exposed to an IgGa antibody fraction and 
antigen  at 0°C for 1 hr,  washed,  and rechallenged with  antibody and antigen 
at  30°C,  showed  a  reduced  net  histamine  release  of  11%  (Table  II).  Thus, 
while  incubation  of peritoneal  cells  alone  at 0°C may have  impaired  slightly 
their  subsequent  response  to challenge  at  30°C,  treatment  with  antigen  and 
antibody at 0°C led to significant inactivation. 776  INTERACTION  OF  IGGA  AND  IGE  AT  THE  TARGI~T  CELL 
The  effect  of  preformed  antigen-antibody  complexes  on  antigen-induced 
release of histamine was also evaluated in this experiment (Table II). An IgGa 
antibody  fraction  and  antigen  were  added  to  medium  lI  at  concentrations 
which  ordinarily produce maximum release of histamine from peritoneal cells. 
The  solutions  were  held for  1  or  10  hr  at  0°C  before  the  addition of target 
cells. Incubation  of cells with either of these mixtures for 30 rain at 30°C  re- 
suited in a net release of histamine of 24%. It should be noted that the release 
of  histamine  by  complexes  formed  during  1  hr  at  0°C  (24%)  exceeded  the 
release  achieved when  the  target cells were  present  together  with  the  com- 
plexes  during  1  hr  at 0°C,  and  the  mixture  subsequently  rewarmed  and  re- 
TABLE II 
Specific Inactivation of Target Cells by Treatment with IgGa Antibody and Antigen at 0  ° and 30°C 
Net 
Prechallenge  treatment  Challenge treatment  histamine 
release 
(%) 
None  Normal*  40 
IgGa antibody, 0°C for 1 hr, wash  Normal  33 
IgGa antibody and antigen, 0°C for 1 hr,$ wash  Normal  11 
None  Preformed complex§  24 
IgGa antibody and antigen, 30°C for 1 hr, wash  Normal  0 
* Conditions as in Fig.  1, paper I(2), except  that  the concentration of the IgGa anti- 
DNP antibody fraction was  1:25,  and antigen concentration for maximum release was 250 
ng DNP-BSA/ml. Duration of challenge was 75 rain. The cells in each tube contained 2000 
ng of histamine; spontaneous  release of histamine was 2.2-6.7%. 
Conditions were the same as for the challenge treatment, using the same concentrations 
of antigen, antibody, and serum. After the first challenge, cells were washed twice in medium 
II and resuspended in 80 ~i of medium II for challenge treatment. There was no net release 
of histamine during challenge at 0°C. 
§ [gGa anti-DNP antibody fraction and antigen were mixed in medium II and held for 1 
hr at 0°C before the addition of peritoneal cells suspended in 80/~1 of medium II. 
challenged (11%). Based on these  observations, it is concluded that the reduc- 
tion in release of histamine  after prolonged incubation of target cells, antigen, 
and IgGa antibody fraction  involves both  a  partial inactivation of the target 
cell and a  decreased effectiveness of preformed complexes. 
Peritoneal cells were also  treated with antigen and  IgGa antibody fraction 
for  1  hr  at 30°C,  washed,  and  rechallenged with  a  fresh dose of antigen  and 
antibody.  No  release  of  histamine  was  observed  after  the  second  challenge 
(Table II),  although  approximately  55%  of  the  initial histamine  present  re- 
mained  within  the  cells. 
Interaction of IgGa and IgE at the Target Cell 
The interaction of IgGa and IgE antibodies at the target cell was evaluated 
in  three  different  experimental  designs:  by  testing  the  effect  of  adding  an MICHAEL  K.  BACH,  KURT  J.  BLOCH,  AND  K.  FRANK  AUSTEN  777 
IgGa anti-DNP antibody fraction and DNP-BSA  antigen at  the time of chal- 
lenge  with  worm  antigen  of  peritoneal  cells  prepared  with  IgE  anti-worm 
antibodies; by testing the effect of  challenging  cells  prepared with IgE  anti- 
worm antibodies with IgGa anti-DNP  antibody and DNP-BSA before chal- 
lenge with worm antigen;  and by testing the effect of the presence of an added 
IgGa  anti-DNP  antibody  fraction  during  the  preparation  step  of  the  IgE 
antibody-mediated system. 
The effect of the IgE antibody-mediated system in  the fluid phase on  the 
IgGa antibody-mediated reaction  was not  investigated.  Rat  anti-worm anti- 
sera rich in IgE antibodies could not be used for this purpose because of the 
TABLE III 
Effect of the Simultaneous Addition of both Nippostrongylus Brasiliensis Antigen and lgGa 
Anti-DNP  Antibody Fraction and DNP-BSA  Antigen to  Calls Previously Prepared with 
Anti-N. Brasiliensis Antiserum Rich in IgE Antibodies* 
Additions during ehallenge~t 
Cells 
prepared with 
IgE antibody 
Net 
histamine 
release 
N. brasiliensis antigen 
IgGa anti-DNP  antibody fraction and DNP-BSA 
IgGa anti-DNP  antibody fraction, DNP-BSA, and N. brasiliensis antigen 
~%) 
19 
25 
54 
* Cells prepared as described in Fig. 1, paper 1(2). Mter washing, cells were suspended in 
80/zl of medium II. 
N. brasiliensis antigen was added at a dilution of 1  : 16, IgGa antibody fraction at 1  : 80 
dilution, and DNP-BSA at 250 ng/ml. The cells in each tube initially contained 1000 ng of 
histamine; spontaneous release was 15%. 
presence  of  IgGa  anti-worm  antibodies  and  because  of  the  interference  of 
nonspecific IgGa in the IgGa antibody-mediated system. 
Combined IgGa and IgE Antibody-Mediated Release of Histamine.--Peritoneal 
cells prepared with rat anti-worm antibodies showed a net release of histamine 
of 19%  on exposure to worm antigen;  similarly prepared cells exposed to an 
IgGa anti-DNP antibody fraction and DNP-BSA antigen showed a net release 
of 25 %. Cells prepared with IgE antibody and exposed simultaneously to both 
specific worm antigen and the mixture of IgGa anti-DNP antibody and DNP- 
BSA showed a  net release of histamine of 54%  (Table III). The slight syner- 
gistic effect observed was not considered to be significant. 
Inactivation  of Cells  Prepared with IgE Antibody by Subsequent Exposure to 
an IgGa Antibody-Antigen  Mixture.--Rat  peritoneal  cells  prepared with IgE 
anti-worm antibodies, washed, and held for 1 hr at 0°C, showed a net histamine 
release of 31% upon challenge with worm antigen at 30°C (Table IV). Another 778  INTERACTION  OF  IGGA  AND  IcE  AT  THE  TARGET  CELL 
sample  of  the  cells prepared  with  IgE  antibodies were  held for  1  hr  at 0°C 
in  the presence of an IgGa anti-DNP  antibody fraction and DNP-BSA  anti- 
gen  and were washed  and  exposed to worm antigen at 30°C;  a  net histamine 
release of  only 5 %  was  observed.  Exposure  of peritoneal cells prepared with 
IgE antibodies to an IgGa anti-DNP antibody fraction and DNP-BSA at 30°C 
for 30 min led to a net release of histamine of 26 %; after washing and exposure 
to worm antigen,  the net release of histamine achieved was  6%.  In contrast, 
cells prepared  with  IgE  anti-worm  antibodies held  at  30°C  for  30  min  and 
TABLE IV 
Effect of Specific Inactivation with IgGa Anti-DNP Antibody 1;raction and DNP-BSA Antigen 
on the Subsequent N. Brasiliensis Antigen-fnduced Rdease of Histamine from Cells Prepared 
Anti-N.  Brasiliensis Antiserum Rich in IgE Antibodies 
Challenge 
treatment~  Prechalienge  treatment of peritoneal  ceils prepared with IgE anti-worm antibodies*  N.  brasiliensis 
antigen 
Net  Net 
Treatment  histamine  histamine 
release  release 
(?:~) 
Control 
60 min at 0°C 
60 min at 0°C plus IgGa anti-DNP antibody and DNP-BSA  2 
30 rain at 30°C 
30 rain at 30°C plus IgGa antibody and DNP-BSA  26 
(%) 
26 
31 
5 
21 
6 
* Ceils prepared with anti-N, brasiliensis antiserum as described in Fig. 1, paper 1(2). 
Washed  cells were suspended  in the equivalent of 80 ~zl of medium  II/3 X  106 cells. The 
cells in each tube contained 1230 ng of histamine. The IgGa antibody fraction was added at 
1:20  dilution and DNP-BSA at 500  ng/ml; spontaneous  release  of histamine was  1%  at 
0°C and 10% at 30°C during prechallenge  treatment. 
~c After intervening treatment, cells were washed and suspended in medium II, using final 
volumes of 500 ~zl/2 )<  10  G  cells for challenge with N. brasiliensls antigen (1:10 dilution in 
medium II, 37°C for 15 min). Spontaneous  release of histamine was 4% for the control cells, 
10% for cells previously held at 0°C, and 7% for cells previously held at 30°C. 
then  challenged with  worm  antigen  in  the  standard  procedure  showed  a  net 
histamine  release  of  21%.  Thus,  pretreatment  of  peritoneal  cells  prepared 
with IgE  anti-worm  antibodies,  with IgGa antibody and  antigen under  con- 
ditions  which  either  do  (30°C)  or  do  not  (0°C)  lead  to  histamine  release, 
markedly inhibited  release  of histamine  provoked  by  specific worm  antigen. 
Competition  by IgGa Antibody  with IgE  Antibody  during  the Preparation  of 
Peritoneal Cells.--The  addition of  IgGa anti-DNP  antibody fraction  to  sera 
rich  in  IgE  anti-worm  antibodies  during  the  preparation  of  peritoneal  cells 
caused a marked decrease in the amount of histamine released during challenge 
with  worm  antigen  (Fig.  3).  This  decrease  was  more  pronounced  the  more 
IgGa anti-DNP antibody fraction added during the preparation step, and fur- ~ICHAEL K. BACH,  KURT J.  BLOCH~ AND  K.  FRANK AUSTEN  779 
thermore,  appeared  to  be  reversed  when  a  higher  IgE  anti-worm  antibody 
concentration was used. It should be stressed  that inhibition  occurred in these 
experiments  without  the  addition  of  DNP-BSA  antigen  during  either  phase 
of  the  IgE  antibody-mediated  reaction. 
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FIG. 3.  Effect of added  IgGa anti-DNP  antibody fraction on the preparation  of mixed 
peritoneal cells with anti-N,  brasiliensis  antiserum  rich in IgE antibodies.  Conditions as in 
paper I, Fig. 1 (2). The cells in each tube initially contained 1500 ng of histamine; spontaneous 
release of histamine was 5-7%.  Results, obtained with a  1:80 dilution of IgE antibody-rich 
serum  (0,  --)  and  with a  1:16 dilution of IgE antibody-rich serum  (O,  -----),  are the 
averages of quadruplicate  determinations and  bars  represent  the standard  deviation of the 
mean. 
DISCUSSION 
Two  lines  of  evidence  indicate  that  firm  binding  of  rat  [gGa  antibody  to 
receptor  sites  2 on  homologous  target  cells  is  not  a  prerequisite  for  the  subse- 
2 The concept of receptor sites for homocytotropic antibodies on target cells is an attrac- 
tive hypothesis; little is known of the surface structure which might be involved. This paper 
suggests that receptor sites may be complex, involving both a binding site and an activation 
site in the pathway to release  of histamine. 780  INTERACTION  OF  IGGA AND  IGE  AT  THE  TARGET  CELL 
quent  antigen-induced  release  of  histamine.  Release  of  histamine  was  not 
improved by interaction of the target cells with IgGa antibody before challenge 
with antigen and washing of target cells previously interacted with IgGa anti- 
body completely  prevented the subsequent antigen-induced release of histamine 
(Table I).  Furthermore, preformed immune  complexes were active at a  con- 
centration of antigen and antibody which was the same as that used routinely 
in  the IgGa  antibody-mediated system. In  contrast,  IgE  antibody not  only 
required a latent period for optimal sensitization (2), but also remained bound 
to the target cell through multiple washings  (10). 
The finding that IgGa antibody does not bind firmly to the target cell may 
account for  the  striking  difference in  the  time  course  of  histamine  release 
observed in  the IgGa antibody-mediated system  (2)  as  compared with  that 
observed in the IgE antibody-mediated system (10). As noted in the companion 
paper (2), release of histamine from cells prepared with rat anti-N, brasiliensis 
antiserum  and  challenged  with  worm  antigen  was  complete within  5  rain. 
Release of histamine  by IgGa  anti-DNP  antibody fraction with  DNP-BSA 
antigen did not reach peak values for 90 rain. The latter observation suggests 
that the IgGa antibody-antigen complex may trigger the release of histamine 
by interacting with multiple activation sites on the target cell because of its 
transient interaction with any one site. It is of interest that an increase in the 
ionic strength of the incubation medium (2) not only diminished the release of 
histamine in  the  IgGa antibody-mediated system  but  also  restricted release 
to the first 5  rain  of interaction. Alteration in ionic strength  of the medium 
may limit the capacity of IgGa antibody-antigen complexes  to interact with 
multiple sites. 
The effect of normal serum in the IgGa antibody-mediated system was two- 
fold. The inhibitory action of normal rat serum in relatively high concentra- 
tion (Fig. 2) was presumably due to competition by nonspecific IgGa and IgE 
antibodies in the fluid phase. Normal mouse serum had been previously reported 
to inhibit  the release  of histamine  from mouse peritoneal cells  treated with 
IgG1 antibody and  antigen  (11).  The basis  of the enhancing effect of serum 
(Fig. 1) is not clear. The enhancement did not require the presence of an intact 
complement  system,  since  C3-deficient  serum  obtained  from  cobra  venom 
factor-treated rats was fully active. 
The inactivation of target cells  by exposure to IgGa antibody and antigen 
in the cold (Table II) most likely reflects the sterile activation of the pathway 
to histamine release. Presumably,  the slowing of energy-generating metabolic 
steps at 0°C prevents release of histamine in  the cold, while the concomitant 
decay of some essential intermediate prevents  the  subsequent  release  of his- 
tamine on rewarming either in the presence or absence of added immune reac- 
tants.  Two lines of evidence suggest that  inactivation results from a  specific 
effect of treatment in the cold on the target cells.  Cells  incubated alone or in MICHAEL  K.  BACH,  KURT  J.  BLOCH,  AND  K.  FRANK  AUSTEN  781 
the presence of IgGa antibody fraction at 0°C and subsequently rewarmed and 
challenged with  IgGa  antibody fraction and  antigen  at  30°C  demonstrated 
nearly normal release of histamine,  and immune complexes preformed at 0°C 
were  capable  of  initiating  the  release  of  histamine  from  target  cells  under 
standard  challenge  conditions.  The  release  of  histamine  provoked  by  pre- 
formed immune complexes was about two-thirds as great as that achieved with 
complexes formed at 30°C in the presence of the target cell. While it is possible 
that a  tightly formed complex is less able to interact with the activation site 
on the target cell than is a  complex in the earlier stages of its formation, the 
effect noted here is less than that observed in a mouse IgG1 system (3). 
In four experiments not presented, rat peritoneal mast cells prepared with 
anti-N,  brasiliensis  antiserum rich in IgE  antibodies failed to be inactivated 
by exposure to worm antigen at 0°C for up to 120 rain. On rewarming the reac- 
tion mixture, histamine release achieved was the same as that of a  duplicate 
cell  preparation  first  challenged  at  the  usual  release  temperature  of  30°C. 
The failure of the IgE  antibody-mediated system studied  to inactivate cells 
upon interaction with antigen at low temperature is in contrast to the observa- 
tions with the IgGa antibody-mediated system investigated (Table II).  Sev- 
eral explanations may be considered. If inactivation of the target cell requires 
sterile activation of a  large proportion of the receptor sites on the cell,  then 
the firm fixation of IgE  antibodies to relatively few sites would limit such  a 
process. Secondly, the biochemical requirements of the IgE antibody-mediated 
pathway may be so limited that the pathway does not decay appreciably after 
sterile  activation.  Finally,  and  perhaps  most  likely,  the  interaction  of  IgE 
antibody and  the worm antigen may not  activate the release mechanism  at 
reduced temperature. 
The interaction between  the  IgGa  and  IgE  antibodies  at  the  target  cell 
appears to involve a  common receptor site and,  at least in part,  a  common 
pathway  to  the  release  of  histamine.  The  evidence for  a  common receptor 
was demonstrated by the ability of IgGa anti-DNP  antibody to diminish the 
capacity of IgE anti-N, brasiliensis antibodies to prepare the target cell during 
a 2 hr incubation period at 30°C for subsequent worm antigen-induced release 
of histamine  (Fig.  3).  Since IgGa antibodies did not bind to the target cell, 
the effective competition between IgGa and IgE antibodies observed may be 
due  to  the  continual,  but  transient,  occupation  of  receptor  sites  by  IgGa 
antibodies present in the fluid phase. Such competition between two immuno- 
chemically distinct  homologous immunoglobulins for sites  on  the  target  cell 
has not been previously observed in model systems. It is not based upon com- 
petition for antigen since the specificity of the two immunoglobulins was dif- 
ferent. 
The interrelationship between IgGa  and IgE  antibodies  at  the  target cell 
is not limited to the receptor site, but also involves some common point in the 782  INTERACTION  OF  IGGA AND  IGE  AT  THE  TARGET  CELL 
pathway  to  mediator release.  The  latter  was  indicated by  the finding that 
incubation of target cells  with IgGa anti-DNP  antibody and antigen at low 
temperature for an appropriate  time period not only inactivated the cell for 
histamine release by the IgGa antibody-mediated system (Table II), but also 
inactivated the cell for histamine release by worm antigen in  the IgE  anti- 
worm antibody-mediated system (Table IV). Additional evidence for a common 
point in the release pathway initiated by interaction of either immunoglobulin 
with specific antigen comes from the finding that activation of an IgE antibody- 
prepared cell by treatment with the IgGa antibody-mediated system at 30°C 
so  as  to  achieve  histamine release  prevents  further histamine release  upon 
challenge at the same temperature with the worm antigen. 
The observation that  the  effects of the IgGa and IgE  antibody-mediated 
systems were additive when combined challenge was carried out (Table III), 
but that they were competitive when employed in sequence to challenge the 
target  cell  (Table  IV)  or  when both  immunoglobulins were  present  during 
the  IgE  antibody  preparation  step  (Fig.  3),  requires  further  comment.  It 
seems most likely that the additive effect observed was related  to  the ability 
of  IgGa  antibody-antigen  complexes  to  find  unoccupied  sites  on  the  IgE 
antibody-prepared  cell  during  the  prolonged  challenge  period.  Under  these 
circumstances,  activation  of  the  pathway  to  histamine  release  by  the  IgE 
antibody-mediated system appears not to interfere with the utilization of the 
same pathway by the IgGa antibody-mediated system. 
Heat-labile homocytotropic antibodies have been recognized functionally in 
the mouse (12) and guinea pig (13) and by both functional and immunochem- 
ical characteristics in the rabbit (14). These same species have also been shown 
to possess heat-stable  7S  immunoglobulins which prepare  a  skin site for cu- 
taneous anaphylaxis (3,  15,  16), or certain target tissues or cells in vitro for 
histamine release  (3,  16,  17). In  the  rat,  IgE  (18)  and IgGa  (5)  antibodies 
have been previously shown to mediate both cutaneous anaphylaxis and the 
intraperitoneal  release  of  histamine.. Monospecific antisera  directed  against 
either of these immunoglobulins removes the activities attributed to one with- 
out affecting those of the other (18, 19). The finding that despite their immuno- 
chemical differences these immunoglobulins share common points of  interac- 
tion at  the  target  cell  may have  broad  implications.  It  has  been  suggested 
that, in the rat, mast cell-bound IgE antibodies mediate the antigen-induced 
release of histamine, while complexes of IgE  antibodies and specific  antigen 
formed  in  the  fluid phase  induce  the  release  of  slow  reacting  substance  of 
anaphylaxis  (SRS-A)  from the  same  target  cell  (18).  Under  in  vivo condi- 
tions in which there !s no time limit for the fixation of IgE antibodies to the 
target cell, nonspecific IgGa would not be expected to compete effectively for 
receptor sites. On  the other hand, under circumstances in which the biologic 
effects  of  IgE  antibodies  depended  upon  a  complex  with  antigen  present 
transiently in  the fluid phase,  nonspecific IgGa would be  expected  to  coin- MICHAEL K. BACH, KURT J.  BLOCH, AND K.  FRANK AUSTEN  783 
pete successfully for receptor sites on target cells. If under these circumstances 
the IgGa and IgE antibodies were  of  the  same  specificity,  then  additive  ef- 
fects would be  expected.  Terr  and Betz  (20)  have reported finding in man  a 
short  latency period  heat-stable  antibody  to  horse  serum  which  mediates  a 
wheal-and-flare reaction in human skin. This antibody may represent an equiva- 
lent of the rat IgGa. The possibility that such antibodies develop during the 
course of immunotherapy of human  allergic disease  must be considered,  and 
if found, their influence on the course of human disease investigated. 
SUMMARY 
IgGa,  in  contrast  to IgE,  antibodies  mediated  the  antigen-induced release 
of histamine from rat peritoneal mast cells without a requirement for a latent 
period and without the capacity to bind firmly to the target cell. Nonetheless, 
IgGa anti-DNP antibody interfered with the capacity of rat anti-N, brasiliensis 
antiserum  rich  in  IgE  antibodies  to  prepare  the  target  cells  for  histamine 
release by worm antigen.  Further,  interaction of IgE antibody-prepared cells 
with IgGa anti-DNP antibody and DNP-BSA at 0°C so as to achieve sterile 
activation,  or  at  30°C  to permit  histamine  release,  inactivated  such  cells  as 
determined  by  the  subsequent  failure  to  release  histamine  upon  challenge 
with  worm  antigen.  Thus,  although  IgE  and  IgGa antibodies  are  immuno- 
chemically distinct  homologous immunoglobulins  and  exhibit  different  func- 
tional  characteristics,  their  interaction  at  the  target  cell  involves a  common 
receptor and at least one common point in the pathway to the release of phar- 
macologic agents from the cell. 
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